World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects

@article{Hasan2013WorldFO,
  title={World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects},
  author={Alkomiet Hasan and Peter G Falkai and Thomas Wobrock and Jeffrey A. Lieberman and Birte Yding Glenth{\o}j and Wagner F. Gattaz and Florence Thibaut and Hans-J{\"u}rgen M{\"o}ller},
  journal={The World Journal of Biological Psychiatry},
  year={2013},
  volume={14},
  pages={2 - 44}
}
Abstract These updated guidelines are based on a first edition of the World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia published in 2006. For this 2012 revision, all available publications pertaining to the biological treatment of schizophrenia were reviewed systematically to allow for an evidence-based update. These guidelines provide evidence-based practice recommendations that are clinically and scientifically meaningful… 

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactation

  • A. HasanP. Falkai H. Möller
  • Psychology, Medicine
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
  • 2015
TLDR
This third part of the updated guidelines covers the management of the following specific treatment circumstances: comorbid depression, suicidality, variousComorbid substance use disorders (legal and illegal drugs), and pregnancy and lactation.

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia – a short version for primary care

TLDR
This summary of the three available evidence-based guidelines for Biological Treatment of Schizophrenia has the potential to support clinical decisions and can improve treatment of schizophrenia in primary care settings.

Acute treatment of schizophrenia: introduction to the Word Federation of Societies of Biological Psychiatry guidelines.

  • F. Thibaut
  • Medicine, Psychology
    Psychiatria Danubina
  • 2014
TLDR
Clinicians must keep in mind that most patients are likely to require long-term, if not life-long, treatment which determines treatment strategy with an optimal balance between efficacy, side effects and compliance.

Evidence-Based Expert Consensus Regarding Long-Acting Injectable Antipsychotics for Schizophrenia from the Taiwanese Society of Biological Psychiatry and Neuropsychopharmacology (TSBPN)

TLDR
The consensus statements developed by the TSBPN provide evidence-based clinical recommendations and could give clinicians more confidence when prescribing LAI antipsychotics to treat schizophrenia, thereby improving treatment outcomes.

Pharmacological guidelines for schizophrenia: a systematic review and comparison of recommendations for the first episode

TLDR
The quality of these guidelines using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) instrument is assessed and recommendations in relation to the key health questions that are relevant to the pharmacological treatment of first-episode schizophrenia are compared.

A systematic review of clinical guidelines on choice, dose, and duration of antipsychotics treatment in first- and multi-episode schizophrenia

Abstract Clinical guidelines provide evidence-based recommendations to regulate pharmacological treatment of psychotic disorders. However, the quality of evidence, country of origin, and publication

A Guideline Review on Treatment-Resistant Schizophrenia: A Focus on Clozapine and other Pharmacotherapeutic Strategies

TLDR
Future iteration of schizophrenia CPGs should address important gaps in information, including strategies to support the safe use of clozapine to decrease treatment delays and reluctance in the use of this effective medication.

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders

TLDR
This guideline takes a holistic approach, addressing all aspects of the care of people with schizophrenia and related disorders, not only correct diagnosis and symptom relief but also optimal recovery of social function, and uses a clinical staging model as a framework for recommendations regarding assessment, treatment and ongoing care.

Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics

TLDR
A systematic literature review of English-language clinical practice guidelines for schizophrenia and synthesized current recommendations for the acute and maintenance management with antipsychotics found all recommending antipsychotic monotherapy, but without agreement on preferred antippsychotic.
...

References

SHOWING 1-10 OF 338 REFERENCES

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance

  • A. HasanP. Falkai H. Möller
  • Medicine, Psychology
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
  • 2012
TLDR
These updated guidelines are based on a first edition of the World Federation of Societies of Biological Psychiatry Guidelines for Biological Treatment of Schizophrenia published in 2005 and provide evidence-based practice recommendations that are clinically and scientifically meaningful.

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia.

TLDR
These guide lines for the biological treatment of schizophrenia were developed by an international Task Force of the World Federation of Societies of Biological Psychiatry to reach a consensus on a series of practice recommendations that are clinically and scientifically meaningful based on the available evidence.

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Acute treatment of schizophrenia

  • P. FalkaiT. Wobrock WFSBP Task Force on Treatment Guidelines for Schiz
  • Psychology, Medicine
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
  • 2006
TLDR
These guidelines for the biological treatment of schizophrenia were developed by an international Task Force of the World Federation of Societies of Biological Psychiatry to reach a consensus on a series of practice recommendations that are clinically and scientifically meaningful based on the available evidence.

The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania

  • H. GrunzeE. Vieta WFSBP Task Force on Treatment Guidelines for Bipol
  • Medicine, Psychology
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
  • 2009
These updated guidelines are based on a first edition that was published in 2003, and have been edited and updated with the available scientific evidence until end of 2008. Their purpose is to supply

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision

  • B. BandelowJ. ZoharE. HollanderS. KasperH. MöllerWFSBP TASK FORCE ON TREATMENT GUIDELINES FOR ANXIE
  • Psychology, Medicine
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
  • 2008
TLDR
Cognitive behavioural therapy (CBT) and other variants of behaviour therapy have been sufficiently investigated in controlled studies in patients with anxiety disorders, OCD, and PTSD to support them being recommended either alone or in combination with the above medicines.

GUIDELINE WATCH (SEPTEMBER 2009): PRACTICE GUIDELINE FOR THE TREATMENT OF PATIENTS WITH SCHIZOPHRENIA: INTRODUCTION

TLDR
This watch highlights key research studies published since APA’s Practice Guideline for the Treatment of Patients With Schizophrenia, Second Edition, was published in April 2004, and points to a reconsideration of treatment with the antipsychotics perphenazine and molindone.

Maintenance treatment with antipsychotic drugs for schizophrenia.

TLDR
The efficacy of antipsychotic drugs for maintenance treatment in schizophrenia was clear and the results of the primary outcome were robust in a number of subgroup, meta-regression and analyses.

The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009.

TLDR
The methods and outcomes of the update process are presented here and resulted in recommendations for 16 psychopharmacologic and 8 psychosocial treatments for schizophrenia, representing significant unmet needs in important treatment domains.

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders.

  • Medicine, Psychology
    The Australian and New Zealand journal of psychiatry
  • 2005
TLDR
These guidelines tackle only one element in the endeavour to reduce the impact of schizophrenia, and evidence-based recommendations for the management of schizophrenia by treatment type and by phase of illness are provided.
...